Skip to main content

Table 2 Serum lipid profiles of study participants by HAART status

From: Highly active antiretroviral therapy and dyslipidemia in people living with HIV/AIDS in Fako Division, South West Region of Cameroon

Parameters

HAART experienced Group (n = 157)

HAART naïve Group (n = 52)

p-value

Total cholesterol, mean ± SD

208.7 (71.9)

147.4 (44.6)

< 0.0001

≥ 200 mg/dL

80 (51.0 %)

5 (9.6 %)

< 0.0001

LDL-cholesterol, mean ± SD

117.6 (68.2)

65.9 (42.0)

< 0.0001

≥ 130 mg/dL

58 (36.9 %)

4 (7.7 %)

0.0001

HDL-cholesterol, mean ± SD

67.0 (62.6)

62.5 (26.3)

0.6153

< 40 mg/dL

22 (14.0 %)

7 (13.5 %)

0.9257

Triglycerides, mean ± SD

117.2 (59.3)

97.7 (57.5)

0.0396

≥ 150 mg/dL

32 (20.4 %)

9 (17.3 %)

0.6257

TC/HDL-cholesterol ratio, mean ± SD

3.7 (2.6)

2.8 (1.7)

0.0205

≥ 5

24 (15.3 %)

3 (5.8 %)

0.0769

  1. HAART- Highly Active Antiretroviral Therapy, TC-Total Cholesterol; HDL-High-Density Lipoprotein, LDL-Low- Density Lipoprotein, SD-Standard Deviation